feed,title,long_url,short_url
Benzinga,FedNat Announces Regular Quarterly Dividend,https://www.benzinga.com/pressreleases/20/11/g18214454/fednat-announces-regular-quarterly-dividend,https://j.mp/3l3kS7S
Benzinga,FedNat Holding Company Announces Formation of Strategic Review Committee,https://www.benzinga.com/pressreleases/20/11/g18214418/fednat-holding-company-announces-formation-of-strategic-review-committee,https://j.mp/2GrmOrE
Benzinga,Celyad Oncology to Present Updates from Allogeneic and Autologous CAR T Programs at 62nd ASH Annual Meeting and Exposition,https://www.benzinga.com/pressreleases/20/11/g18214370/celyad-oncology-to-present-updates-from-allogeneic-and-autologous-car-t-programs-at-62nd-ash-annua,https://j.mp/3mXiErj
Benzinga,Fulcrum Therapeutics Announces Multiple Presentations During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition,https://www.benzinga.com/pressreleases/20/11/g18214364/fulcrum-therapeutics-announces-multiple-presentations-during-the-62nd-american-society-of-hematolo,https://j.mp/3jYBigu
Benzinga,"Rattler Midstream LP, a Subsidiary of Diamondback Energy, Inc., Reports Third Quarter 2020 Financial and Operating Results",https://www.benzinga.com/pressreleases/20/11/g18214359/rattler-midstream-lp-a-subsidiary-of-diamondback-energy-inc-reports-third-quarter-2020-financial-a,https://j.mp/3mPLPwg
Benzinga,Keros Therapeutics to Present at the Virtual 62nd American Society of Hematology Annual Meeting and Exposition,https://www.benzinga.com/pressreleases/20/11/g18214358/keros-therapeutics-to-present-at-the-virtual-62nd-american-society-of-hematology-annual-meeting-an,https://j.mp/2TTlGQH
Benzinga,Nurix Therapeutics to Present Preclinical Data at Upcoming 5th Medicinal Chemistry & Protein Degradation Summit and 62nd ASH Annual Meeting and Exposition,https://www.benzinga.com/pressreleases/20/11/g18214357/nurix-therapeutics-to-present-preclinical-data-at-upcoming-5th-medicinal-chemistry-protein-degrada,https://j.mp/3epyPdM
Benzinga,G1 Therapeutics Provides Third Quarter 2020 Corporate and Financial Update,https://www.benzinga.com/pressreleases/20/11/g18214356/g1-therapeutics-provides-third-quarter-2020-corporate-and-financial-update,https://j.mp/3eDc32p
Benzinga,QorvoÂ® Announces Fiscal 2021 Second Quarter Financial Results,https://www.benzinga.com/pressreleases/20/11/g18214296/qorvo-announces-fiscal-2021-second-quarter-financial-results,https://j.mp/3epAv7b
Benzinga,Cytokinetics Reports Third Quarter 2020 Financial Results,https://www.benzinga.com/pressreleases/20/11/g18214293/cytokinetics-reports-third-quarter-2020-financial-results,https://j.mp/2I9fph2
